Medly AI
25 employees on LinkedIn · 7 known investors
London-based edtech company offering an AI tutoring and exam-preparation platform for GCSE, A-Level, IB, SAT and university students.
Also known as Medly · Medly AI Ltd
Founders & leadership
Investors · 7
.jpeg){kind=logo}
Also in the syndicate · 4
Company profile
researched Aug 2026Medly AI (operating as Medly, legal entity Medly AI Ltd, England and Wales company no. 15110302) runs an online AI tutoring platform for exam preparation. The product maps questions to specific exam boards and specifications, marks student answers against exam-style mark schemes, and returns itemised feedback on where marks were earned or lost. Core features include an adaptive question engine drawing on a knowledge graph and a bank of more than 6,000 exam-style questions, study plans built around a target grade and available daily study time, a 24/7 AI tutor that guides students towards answers rather than supplying them, essay marking against exam criteria, timed full-length mock exams (Medly Mocks, run twice a year and free), and handwriting recognition for tablet or stylus input in subjects such as maths and chemistry. Learn Mode, launched in February 2026, adds structured lessons aligned to specifications followed by targeted practice questions.
Coverage spans GCSE (AQA, Edexcel, OCR, WJEC), A-Level (AQA, Edexcel, OCR, CIE), IGCSE (CIE, Edexcel), the IB Diploma Programme, and AP and SAT via the College Board, across sciences, maths, humanities, languages and social sciences. A separate university-focused offering, referred to as Medly Open, lets students upload lectures, readings and notes, extracts key points, provides summaries and explanations of highlighted material, and generates custom practice tests in the style of their own assessments. Content is reviewed and edited by practising teachers. The company also states a policy of not writing full essays or supplying direct answers to assignments, and describes a commitment to sustainable AI practices.
Founding story
Medly was founded by Dr Paul Jung, co-founder and CEO, and Dr Kavi Samra, co-founder, both graduates of medicine at UCL. Jung has framed the company's purpose around access to private tutoring, noting that almost a third of 11-16-year-olds receive some form of private tuition, which advantages those who can afford it and entrenches existing outcomes for those who cannot.
Business model
Subscription access to the AI tutoring platform. Terms of use define individual subscriptions covering a named student, free trial memberships, and per-account device limits (a maximum of five devices in any 30-day period and one device logged in at a time). Users can sign up free without a credit card. The company also markets a schools offering (Medly for School) alongside its direct-to-student products.
Paid individual subscriptions to the platform, with a free sign-up tier and free trials as entry points; the company positions its pricing as a fraction of the cost of private tutoring. Full-length Medly Mocks are offered free.
Traction
More than 400,000 students have used the platform, with roughly 90,000 monthly active users and average daily engagement of 38 minutes as reported by the company (other coverage cites around an hour of daily use). In the company's GCSE 2025 analysis, 74% of surveyed students improved their grades while using Medly and 40.5% improved by two or more grades. A trial with more than 1,000 students is under way to assess the platform's impact on attainment.
Latest developments
In August 2026 Medly AI announced an $8M seed round led by Felix Capital with Eka Ventures, Ada Ventures and several angel investors, taking total funding to about $12M. Proceeds are earmarked for growing the UK student community, international expansion (scaling SAT, AP and ACT preparation in the US), developing additional AI capabilities including proprietary marking and pedagogy models and features for study beyond standard exam curricula, and expanding research into academic outcomes. Learn Mode launched in February 2026.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
A UK-based exam-preparation specialist in the edtech AI tutoring market, positioning itself against general-purpose assistants such as ChatGPT on curriculum alignment, exam-board-specific question mapping and marking against official mark schemes, and against private human tutoring on cost and availability.
Alignment of every question to a named exam board and specification, teacher-reviewed content, marking against exam-style mark schemes with mark-by-mark breakdowns, a Socratic tutoring stance that guides students rather than providing answers or writing essays outright, handwriting recognition for maths and science working, and an adaptive engine driven by a curriculum knowledge graph and spaced-repetition principles.
Technology
The platform is built on a proprietary combination of seven large language models, described as frontier models adapted for exam marking, combined with approaches drawn from neuroscience, teaching theory and pedagogy. An adaptive question engine uses a knowledge graph of curriculum relationships to select from over 6,000 exam-style questions, weighted towards topics with the greatest expected score impact. Additional components include AI marking trained on exam-style marking criteria, fine-tuned handwriting recognition, and automated extraction of key points and question generation from uploaded lecture material. The company says it is developing proprietary models for specific educational functions such as marking and pedagogy, and describes its methodology and algorithms as trade secrets.
Go-to-market
Primarily self-serve, free sign-up at app.medlyai.com with conversion to subscription, supported by strong word-of-mouth growth, published student testimonials and results analyses, a content/blog channel, and a separate schools track. Geographic go-to-market began in the UK with expansion into the US via SAT, AP and ACT preparation.
Students preparing for GCSE (Years 10-11), A-Level (Years 12-13), IGCSE (Cambridge and Edexcel international curricula), IB Higher and Standard Level subjects, and AP and SAT exams in the United States, across all ability levels; university students via the lecture-based Medly Open product; parents supporting their children's revision; and schools.
Geography
Headquartered in London, UK, with a registered office at 85 Great Portland Street, London W1W 7LT. The user base of over 400,000 is in the UK; the site serves UK and US regions, and the company has launched SAT preparation in the US with AP and ACT support planned.
History
The platform launched in February 2025. Its UK user base grew from about 100,000 in early 2025 to more than 400,000, growth the company attributes largely to word of mouth. Learn Mode, which integrates structured lessons into the practice flow, launched in February 2026. The company began international expansion with a US SAT preparation launch, and in August 2026 announced an $8M seed round led by Felix Capital that brought total funding to about $12M.
Risks & controversies
The company states that its platform is a supplementary educational tool and not a replacement for qualified human instruction or formal coursework. Service access is restricted to users aged 14 and over, and accounts may be terminated for credential sharing or exceeding device limits. Reported grade-improvement figures are drawn from the company's own surveys and analysis, with an independent-style attainment trial still in progress.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 4
launches, deals, and filingsMedly AI announced an $8M seed round led by Felix Capital with participation from existing investors Eka Ventures and Ada Ventures and angels Andrey Dobrynin (CEO of InvestEngine), Al Giles (Venture Partner at Creator Fund), Jean Hammond (General Partner at LearnLaunch Accelerator) and Hector Mason (General Partner at Episode 1 Ventures). Coverage reported total funding of about $12M. Funds are for UK student growth, international expansion including SAT, AP and ACT preparation in the US, further AI development and research into learning outcomes.
$8M source ↗
Medly began international expansion, recently launching SAT preparation in the US, with plans to add AP and ACT support by the end of the year.
Learn Mode integrates structured lessons aligned to exam specifications directly into the practice experience, followed by targeted questions.
Medly's AI tutoring and exam preparation platform launched in February 2025.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Medly AImedlyai.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Medly AI do?
- London-based edtech company offering an AI tutoring and exam-preparation platform for GCSE, A-Level, IB, SAT and university students.
- Who founded Medly AI?
- Medly AI was founded by Paul Jung, PhD, Kavi Samra.
- Who are Medly AI's investors?
- Medly AI's investors include Eka Ventures, FELIX CAPITAL, Ada Ventures.